lenalidomide
- Product NDC
- 69097-381
- 11-digit product format
- 690970381
- Labeler code
- 69097
- Product ID
- 69097-381_6b77715c-f6f7-408c-8efd-bfdd3125aec4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lenalidomide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA210435
- Marketing category
- ANDA
- Marketing start
- 2022-09-06
- Substance
- LENALIDOMIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Thalidomide Analog [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- lenalidomide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LENALIDOMIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F0P408N6V4 |
| Rxcui | 602910, 602912, 643712, 643720, 1428947 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-381-73 | lenalidomide | 28 in 1 BOTTLE, PLASTIC | CAPSULE | 28 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-381 | LENALIDOMIDE CAPSULE [CIPLA USA INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20250104_ba2a07fd-ca60-40bc-b79b-9caf81900fa3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-381-73 | 69097038173 | 28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73) | 28 capsule | 2022-09-06 | 0000-00-00 | No | No | Current |